Hunt names the problem with a striking phrase: an asymmetry of grace. The field extends generosity in one direction while withholding it in the other. Researchers without diagnoses are invited to study mental distress as an external object, and their interpretations are accepted as scientific contributions. Researchers with diagnoses, by contrast, find that the same experiences they are paid to analyze are treated as disqualifying when they surface in their own lives. A colleague may publish on depression for thirty years and be regarded as authoritative, but if that colleague discloses a depressive episode, the disclosure can suddenly reframe their competence, their reliability and even the credibility of their data. The knowledge is welcome; the knower is not.

The argument lands at a moment when the evidence base on stigma in academic and clinical settings has never been stronger. A major synthesis published in The Lancet in 2022, led by Graham Thornicroft and colleagues, consolidated decades of work showing that stigma and discrimination against people with mental illness remain pervasive across health systems, workplaces and societies, and that social contact and structural interventions are needed to reduce them. Hunt’s point is that the research enterprise itself is one of those structures. If the Lancet synthesis describes the scale of the problem in society at large, her World View asks an uncomfortable internal question: to what extent does the machinery of mental-health science reproduce the very stigma it studies?

Part of the answer lies in how the field values different kinds of knowledge. The tradition of critical scholarship known as Mad Studies, represented in collections such as Mad Matters, edited by Brendan LeFrançois, Robert Menzies and Geoffrey Reaume, has long insisted that people who have experienced madness and psychiatric treatment are holders of knowledge, not merely subjects of it. Philosophical work such as Mohammad Abou Rashed’s Madness and the Demand for Recognition has framed mental-health activism as a struggle over identity and epistemic authority. Hunt’s contribution is to apply this lens to the laboratory, the department and the grant review panel. She observes that the same institutions that cite Mad Studies approvingly may still operate personnel practices, disclosure norms and informal cultures that make it dangerous for a researcher to say out loud what their research is about.

The asymmetry becomes visible in small, everyday mechanisms. A researcher without lived experience can discuss suicidal ideation in a seminar with clinical detachment and be praised for rigor. A researcher with lived experience who raises a hand to say that a proposed measure feels wrong, or that a recruitment script is degrading, risks being labeled as too close, too invested, or insufficiently objective. Objectivity, in this arrangement, is quietly defined as distance, and distance is quietly defined as not having been ill. That definition does real epistemic damage. It filters out exactly the experiential knowledge that co-production frameworks claim to want, and it teaches early-career researchers with mental illness that advancement requires concealment.

Concealment carries its own costs, and the professional literature is beginning to document them. Hunt draws on recent work examining disclosure and mental health in research and professional contexts, including an analysis published in Critical Public Health in 2026, to show that the decision of whether to disclose a mental-health condition in an academic career is shaped by anticipated consequences rather than by any neutral calculus. When the anticipated consequences include lost opportunities, subtle exclusion or doubts about one’s fitness to work, the rational choice for many is silence. Silence, multiplied across a workforce, produces a distorted picture of the profession itself: a mental-health research community that appears, on the surface, to be remarkably free of mental illness.

The irony is sharpened by parallel debates in clinical publishing. A 2025 commentary by P. Sharma in PLOS Mental Health raised the question of whether health professionals should be required to disclose mental-health conditions, probing the tension between patient safety arguments and the discriminatory potential of mandatory disclosure regimes. Hunt’s World View extends that debate from the clinic to the research institute. The underlying logic is the same: in both settings, a diagnosis is treated as a risk factor to be managed rather than a characteristic of a competent professional, even though the prevalence of common mental disorders among highly educated, high-functioning adults is well documented and entirely compatible with excellent work.

Calling the problem structural has specific technical meaning in this context, and Hunt uses it deliberately. A structural issue is one embedded in rules, incentives and default practices rather than in the malice of individuals. Grant applications that reward polished, untroubled biographies are structural. Promotion criteria that never recognize the additional labor of navigating a health condition while producing research are structural. Conference cultures in which disclosure happens only in whispered corridor conversations are structural. So is the pattern, familiar from the sociology of professions, in which the gatekeepers of a discipline define themselves against the population they study. None of these mechanisms requires anyone to hold prejudiced beliefs; they simply make disclosure costly and concealment safe, and over time that incentive landscape shapes who stays in the field and who leaves.

What would a structural remedy look like? Hunt’s argument implies several directions that follow directly from the evidence she cites. Anti-stigma interventions with demonstrated effectiveness, such as the social-contact approaches emphasized in the Lancet synthesis, need to be applied inside research institutions, not only in schools, workplaces and clinics. Co-production frameworks need teeth: if lived experience is genuinely an asset, then disclosure must be protected, and researchers who bring it should face no penalty in hiring, funding or authorship decisions. Professional bodies and journals can normalize disclosure by treating it as unremarkable, in the same way that institutions have gradually normalized other forms of personal disclosure. And the field can take Mad Studies’ core epistemic claim seriously in practice, treating researchers with mental illness not as a vulnerable population to be accommodated but as colleagues whose vantage point is part of the discipline’s scientific toolkit.

The stakes extend beyond fairness, though fairness would be reason enough. Mental-health research aims to produce knowledge that improves the lives of people with mental illness, and a workforce in which lived experience must be hidden is a workforce operating with one channel of evidence muffled. The history of patient movements in medicine, from HIV activism to disability rights, shows that outcomes improve when the people affected by a condition help steer the science about it. Hunt’s World View, published on 9 October 2026, is a compact statement of what mental-health science must fix in its own house to earn that kind of legitimacy. The grace the field extends to the people it studies, she suggests, will only be credible when it is extended, in equal measure, to the people it employs.

Subject of Research: Structural stigma against mental-health researchers with lived experience

Article Title: Asymmetries of grace are a structural issue

Article References: Hunt, X. (2026). Asymmetries of grace are a structural issue. Nature Mental Health. https://doi.org/10.1038/s44220-026-00733-2

Image Credits: AI Generated

DOI: 10.1038/s44220-026-00733-2

Keywords: mental health research, lived experience, stigma, disclosure, Mad Studies, co-production, Xanthe Hunt, Nature Mental Health, epistemic injustice, academic careers, structural inequality, research workforce

The stakes could hardly be higher. Public trust in journalism has been declining for years, and news avoidance is rising across democratic societies. Surveys consistently show that audiences are sceptical about AI in news, distrust fully automated content, and want publishers to be open about their use of the technology. Yet the same research reveals a paradox that has come to be known as the transparency backfire: disclosing AI involvement can itself reduce trust in news, making readers question content that was, in fact, produced or checked by human journalists. Publishers are therefore caught between an ethical obligation to disclose and a commercial imperative not to undermine the very credibility that makes people pay for journalism. As one senior FT manager put it bluntly in the study: mistrust is the top threat, because once you lose that, you forget the rest.

The study finds that the FT operationalises transparency through a hybrid of policy, process, and practice, underwritten by explicit endorsement from the very top of the organisation. Editor in Chief Roula Khalaf has publicly committed the newsroom to transparency, promising that all newsroom experimentation will be recorded in an internal register. The FT’s internal AI Principles state that the organisation will not allow AI to compromise the integrity of its journalism, which will be reported, written, and created by journalists and editors, while permitting experimentation with secondary content such as summaries, alt-text, captions, and translations, provided there is appropriate disclosure. New AI applications are vetted by cross-functional AI Use Case Panels, which decide whether a use case is approved and advise on the appropriate level of transparency. Some red lines are absolute: the FT does not generate photographic imagery with AI, except for clearly flagged illustrations in stories about AI itself.

Internally, transparency functions as a trust-building and risk-management mechanism rather than a public relations exercise. The FT’s internal AI Policy places accountability squarely on staff, requiring them to review AI output as if they had created it themselves. If an AI-generated summary contains an error, the journalist whose name appears on the story bears the responsibility just as before. AI functionality inside the content management system is signposted with the now-familiar sparkle emoji, accompanied by reminders that generated content may contain hallucinations. Technical systems even highlight portions of AI output that are statistically more likely to contain errors, directing human attention where it matters most. Regular sharing sessions across editorial, product, and technology teams, an intranet serving as a single source of truth, and an AI Transformation group designed to prevent information silos all reinforce the message. Managers described a culture in which even senior leaders are willing to admit they do not know, backed by what one participant called a lot of data and checks, and kill switches the whole way along.

Externally, the FT calibrates the prominence of disclosure to the degree of autonomy in the system. The clearest illustration is the contrast between two reader-facing features. Ask FT, a generative chatbot that lets subscribers interrogate nearly two decades of archival reporting, operates with no human in the loop, and therefore carries a strong disclaimer informing users they are interacting with an AI system provided by Anthropic rather than a human. Bullet-point summaries, by contrast, are generated by a language model but sit within articles subject to editorial oversight, and receive lighter labelling. The FT’s internal Responsible AI Guidelines codify this logic: the more automatic or impactful a process, or the larger the proportion of output generated by AI, the more prominent the disclosure should be. When in doubt, disclosure is the default option.

The researchers identified nine factors that systematically shape what, when, and how the FT discloses AI use to readers. Legal and provider requirements come first: some AI vendors contractually mandate disclosure, down to Google Translate’s requirement for a specific logo and a paragraph of capitalised text. Industry benchmarking follows, with the FT studying how publishers such as the New York Times, the Washington Post, and Aftonbladet, along with the BBC’s published AI transparency guidelines, approach the same problems. The nature of the task matters too: behind-the-scenes AI used by the search engine optimisation team, whose output never reaches readers directly, goes undisclosed. The degree of human oversight, the novelty and uncertainty of the system, audience expectations gathered through usability testing and pre- and post-deployment research, the perceived risk of harm or error, commercial sensitivities such as the cost of documenting AI methods in investigative work, and finally design constraints, including the limited screen real estate of mobile devices, all weigh on every disclosure decision.

That last point deserves emphasis, because it reveals how mundane the mechanics of transparency can be. Readers, the FT found, find AI disclosures far more obvious on desktop than on mobile, where there is simply less space to call out specific elements. Designers debated the background colour of AI-generated elements to signal that this is not the journalism itself but something layered on top. The sparkle emoji was adopted partly because readers already understood it and it was becoming an industry-wide standard. Yet cluttering pages with tiny explanatory text, one manager argued, becomes less and less helpful as AI use becomes intuitive to users. Transparency, in other words, is a design problem as much as an ethical one, and the optimal solution shifts as audiences grow accustomed to the technology.

The study also documents five cross-cutting challenges that persist despite the FT’s considerable resources. Achieving consistent, site-wide labelling remains elusive, with participants acknowledging the organisation still lacks a unified agreement on design components and transparency guidelines. Internal communication struggles against silos and fatigue: one manager estimated that no more than a couple hundred of the FT’s three and a half thousand staff had read the responsible AI framework. Standards themselves are moving targets, as models improve and public familiarity grows, prompting the question of when AI becomes just another editorial tool that no longer needs labelling, much as streaming platforms run recommendation algorithms without pop-up warnings. Human over-reliance on confident tools is an anticipated future risk. And audience misinterpretation is real: in usability testing, some participants assumed that the mere presence of an AI tool in an article meant the article itself had been machine-generated.

Beneath these practical difficulties, the researchers identified deeper tensions rooted in what institutional theorists call competing logics. Editorial participants framed transparency primarily in terms of reputation, accuracy, and accountability; product and analytics staff emphasised whether disclosure was intelligible at the point of use; legal and policy voices foregrounded provider requirements and liability exposure. The study interprets these dynamics through the lens of isomorphic pressure, the well-documented tendency of organisations to model themselves on peers under uncertainty. Regulation such as the EU AI Act exerts coercive pressure, professional norms and charters like the Paris Charter on AI and Journalism exert normative pressure, and the absence of any settled best practice drives mimetic copying of other leading publishers. Transparency at the FT is thus not owned by any single department; it is a site of ongoing cooperation and occasional conflict between professional, managerial, and commercial priorities.

The authors’ central argument is that AI transparency in news is best understood as a spectrum rather than a binary, a lived governance practice that evolves with technological capability, commercial reality, professional ethics, and shifting audience attitudes. Optimising for one factor, such as maximal disclosure demanded by regulators, can come at the expense of audience trust or revenue when transparency itself breeds distrust. The study offers several no-regret principles for other organisations: scale disclosure with a system’s autonomy and impact, pair AI labels with concise and comprehensible explanations, continuously measure how users actually interpret them, keep internal transparency and accountability high even when external disclosure is light, and favour consistent, reusable design components across products and platforms. The research carries limitations, being a single-organisation case study reliant on interviews and documents rather than ethnographic observation, with an insider researcher whose access was both asset and potential bias, mitigated by external ethical review and independent co-analysis. Still, its message resonates far beyond one newsroom: in the age of generative AI, telling audiences the truth about how the news is made is simple in principle, fiendishly complex in execution, and never a decision you make just once.

Subject of Research: AI transparency practices and disclosure decision-making in a major news organisation

Article Title: Tricky trade-offs on a transparency spectrum: how the Financial Times approaches transparency about AI use in news

Article References: Lohn, L., & Simon, F. M. (2026). Tricky trade-offs on a transparency spectrum: how the Financial Times approaches transparency about AI use in news. AI & SOCIETY. https://doi.org/10.1007/s00146-026-03369-z

Image Credits: AI Generated

DOI: 10.1007/s00146-026-03369-z

Keywords: artificial intelligence, journalism, transparency, Financial Times, generative AI, newsroom, trust in news, media ethics, disclosure, EU AI Act, audience trust, institutional logics

Nova, a food classification system developed by researchers at the University of São Paulo, categorizes foods not by their nutrient content but by the degree and purpose of the industrial processing they undergo. The system’s fourth and most scrutinized category, ultra-processed foods, includes many packaged snacks, candy, sweetened beverages, and ready-to-eat products — foods manufactured with industrial ingredients and additives that consumers rarely use in home cooking. Over the past decade, Nova has become the backbone of a growing body of research linking higher consumption of ultra-processed foods to poorer health outcomes, including weight gain, cardiovascular disease, and other chronic conditions. That evidence base has, in turn, informed dietary recommendations and policy debates from Brazil to the United Kingdom, making Nova one of the most consequential frameworks in modern nutrition science.

But Nova has also attracted sustained criticism. Some researchers argue that the system lumps together nutritionally dissimilar products, that it overemphasizes processing at the expense of nutrient profiles, and that its categories are too vague to support sound policy. These critiques are not fringe positions; they appear in peer-reviewed journals and shape how policymakers interpret the evidence on ultra-processed foods. What has been far less clear is whether the researchers making these arguments bring independent perspectives — or undisclosed commercial interests — to the debate. LaFata and her colleagues set out to answer precisely that question using a systematic review, one of the most rigorous tools available for synthesizing a body of literature.

The team systematically identified 69 academic articles published between 2009 and 2025 that either criticized Nova or described potential benefits of ultra-processed foods. They then examined the industry relationships of the 232 authors across those articles, drawing on two sources: conflicts of interest disclosed within the articles themselves and additional relationships identified exclusively through publicly available information, such as corporate advisory roles, consulting arrangements, and funding records. This dual approach was designed to capture ties that authors may not have reported to journals, a persistent problem across biomedical research.

The results were striking. Fully 91.3 percent of the articles included at least one author with an identified food industry relationship. At the individual level, more than two-thirds of the authors — 68.5 percent — had some form of industry tie. Even more revealing was the disclosure gap: for 71.1 percent of the authors with identified industry relationships, those ties were found only through publicly available sources rather than through the formal conflict-of-interest disclosures attached to the articles. In other words, in most cases a reader of the original article would have had no way of knowing, from the article itself, that the authors had commercial relationships relevant to the topic at hand.

The analysis also uncovered a pattern in the content of the articles themselves. Articles involving authors with industry relationships were more likely to defend the food industry’s position or promote potential benefits of ultra-processed foods than articles written by authors with no identified industry ties. While the study’s design does not establish that industry relationships caused the critical positions — it is possible that companies seek out academics who already hold skeptical views — the association is difficult to dismiss in a field whose findings feed directly into regulatory decisions. The systematic review’s methodology, which included clearly defined criteria for identifying and classifying both the articles and the industry relationships, lends considerable weight to the pattern it documents.

LaFata is careful to frame the findings as a call for transparency rather than a wholesale dismissal of Nova’s critics. “This study is not saying that criticism of Nova is illegitimate,” she said, noting that “some of those criticisms identify real ways the system can be improved.” Any classification scheme as ambitious as Nova — one that attempts to sort the entire food supply by industrial processing rather than nutrients — is fair game for scientific scrutiny, and legitimate methodological critiques can strengthen the science. The concern, she argued, is not criticism itself but the possibility that readers, journalists, and policymakers cannot see who is behind it. “But readers should know who is shaping that debate,” she said. “When most of the published criticism involves authors with food industry relationships, and many of those relationships are not disclosed, transparency becomes especially important.”

The implications extend well beyond academic circles. Dietary guidelines, front-of-package labeling schemes, tax policies on sugary drinks, and school food standards are all increasingly informed by research on ultra-processed foods, and Nova sits at the center of that evidence base. If a substantial share of the published criticism of that framework comes from authors with undisclosed industry relationships, the apparent scientific controversy around Nova may look different once the affiliations behind it are visible. This dynamic — in which commercial interests shape scientific debate through apparently legitimate academic channels — echoes patterns documented in earlier public health fights over tobacco, sugar, and alcohol, where industry-funded research and industry-connected experts played measurable roles in delaying or diluting policy responses.

The study’s authors argue that the findings underscore the need for stronger transparency practices across nutrition research. Journals could tighten conflict-of-interest disclosure requirements and verify author statements against public records. Readers and journalists evaluating claims about ultra-processed foods could weigh the industry relationships of the researchers making those claims. Policymakers relying on the scientific literature to craft dietary guidance could ask not only what the evidence says, but who produced it and under what financial arrangements. None of these steps requires assuming bad faith on the part of any individual researcher; they simply acknowledge that financial relationships are relevant context for evaluating scientific arguments, particularly when those arguments concern the products of the companies involved.

As the debate over ultra-processed foods intensifies — with regulatory agencies, legislatures, and international health bodies all taking a closer look at the science — this systematic review provides a rare empirical window into that debate’s structure. Its central message is straightforward: criticism of Nova, like any scientific argument, deserves engagement on its merits, but the terms of that engagement change when the affiliations of its proponents remain hidden. With more than two-thirds of the field’s Nova critics holding food industry ties and most of those ties absent from formal disclosures, the study makes the case that transparency is not a bureaucratic nicety in nutrition science. It is a prerequisite for an honest public conversation about one of the most pressing questions in modern diet and health.

Subject of Research: A systematic review of food industry affiliations among researchers who criticize the Nova food classification system.

Article Title: Who’s shaping the debate over ultra-processed foods?

Article References: Who’s shaping the debate over ultra-processed foods?. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: ultra-processed foods, Nova classification, food industry ties, conflict of interest, nutrition research, systematic review, public health, transparency, disclosure, American Journal of Public Health, Oregon Research Institute, food policy